September 20, 2023 by TAC RESEARCH WEEKLY: The challenges of parenting with SMI

By Shanti Silver (September 20, 2023) Approximately 4% of parents in the United States live with a serious mental illness. While there has been a growing awareness of the unique challenges […]

20 September 2023
September 6, 2023 by TAC RESEARCH WEEKLY: Early detection for psychosis on college campus

By Hope Parker (September 6, 2023) Reducing the duration of untreated psychosis is vital to improving quality of life and long-term outcomes. Early detection programs that identify and refer individuals with early […]

06 September 2023
August 23, 2023 by TAC NIMH funding priorities still failing people with SMI

By Shanti Silver (August 23, 2023) Schizophrenia and bipolar disorder are two of the most difficult mental illnesses to treat. Accordingly, funding for research into treatments that improve quality of […]

23 August 2023
August 2, 2023 by TAC RESEARCH WEEKLY: The Clozapine REMS

By Shanti Silver(August 2, 2023) Clozapine is the only FDA-approved medication for treatment-resistant schizophrenia but remains underutilized in the United States and around the world. In this week’s “Research Weekly,” […]

02 August 2023
June 13, 2023 by TAC RESEARCH WEEKLY: Marijuana and schizophrenia

By Elizabeth Sinclair Hancq (June 13, 2023) Avid readers of this blog would know that we have written frequently on the potential connection between cannabis use, commonly known as marijuana, […]

13 June 2023